MAYINGLONG PHARMACEUTICAL GROUP CO., LTD.

Consensus Mayinglong Pharmaceutical Group Co., LTD.

Equities

600993

CNE000001HN2

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
27.81 ^CNY	+0.40%		-2.18%	+15.01%

Apr. 19	Mayinglong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 17	Mayinglong Pharmaceutical Receives Registration Approval for New Colorectal Treatment	MT

Evolution of the average Target Price on Mayinglong Pharmaceutical Group Co., LTD.

Price target over the last 5 years

History of analyst recommendation changes

55bf861e846bb98ba9b07.9DPx3ZQegGvk0IrBjzshFYhqMLYGjfAKe3-wFQHYQjA.umyX7uVE5j3Stv2I2H15UfoMSv4137hdCQzzREatGFmAVYa34k7DG7unxw~fe0f2ef7d5bfd2f712fb5e2049f5e5c9

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

27.81 CNY

Average target price

35 CNY

Spread / Average Target

+25.85%

High Price Target

35 CNY

Spread / Highest target

+25.85%

Low Price Target

35 CNY

Spread / Lowest Target

+25.85%

Consensus detail

Consensus revision (last 18 months)

Chiffre d''affaires - Rate of surprise

Company calendar